Filing Details

Accession Number:
0001237899-14-000020
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-02-13 19:38:09
Reporting Period:
2014-02-12
Filing Date:
2014-02-13
Accepted Time:
2014-02-13 19:38:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1225472 M Eric Shooter 777 Old Saw Mill River Road
Tarrytown NY 10591
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-02-12 5,000 $177.82 5,000 No 4 M Direct
Common Stock Acquisiton 2014-02-12 5,000 $57.11 10,000 No 4 M Direct
Common Stock Acquisiton 2014-02-12 5,000 $33.42 15,000 No 4 M Direct
Common Stock Disposition 2014-02-12 12,878 $320.41 2,122 No 4 S Direct
Common Stock Disposition 2014-02-12 2,122 $321.22 0 No 4 S Direct
Common Stock Acquisiton 2014-02-12 7,000 $0.00 7,000 No 4 C Indirect by Trust
Common Stock Disposition 2014-02-12 7,000 $0.00 0 No 5 G Indirect by Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 C Indirect by Trust
No 5 G Indirect by Trust
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Class A Stock Disposition 2014-02-12 7,000 $0.00 7,000 $0.00
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-02-12 5,000 $0.00 5,000 $33.42
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-02-12 5,000 $0.00 5,000 $57.11
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2014-02-12 5,000 $0.00 5,000 $177.82
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
85 No 4 C Indirect
0 2021-01-03 No 4 M Direct
5,000 2022-01-03 No 4 M Direct
10,000 2023-01-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,500 Indirect GRAT self
Common Stock 2,500 Indirect GRAT spouse
Footnotes
  1. Represents volume-weighted average price of sales of 12,878 shares of Company stock on February 12, 2014 at prices ranging from $320.00 to $320.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
  2. Represents volume-weighted average price of sales of 2,122 shares of Company stock on February 12, 2014 at prices ranging from $321.00 to $321.49. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on February 12, 2014 at each separate price.
  3. Gift of Common Stock to a charitable foundation.
  4. Class A Stock of Regeneron Pharmaceuticals, Inc. ("Regeneron") converts to Common Stock of Regeneron on a one-to-one basis upon certain events or upon election of the shareholder.
  5. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.
  6. Shares of Class A Stock are convertible at any time on a share-for-share basis into Common Stock.
  7. The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.